SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-151851
Filing Date
2022-05-16
Accepted
2022-05-16 16:34:57
Documents
58
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d232947d10q.htm   iXBRL 10-Q 883639
2 EX-31.1 d232947dex311.htm EX-31.1 10532
3 EX-31.2 d232947dex312.htm EX-31.2 10551
4 EX-32.1 d232947dex321.htm EX-32.1 4714
5 EX-32.2 d232947dex322.htm EX-32.2 4661
  Complete submission text file 0001193125-22-151851.txt   4394013

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA abos-20220331.xsd EX-101.SCH 37942
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abos-20220331_cal.xml EX-101.CAL 34642
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abos-20220331_def.xml EX-101.DEF 194135
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abos-20220331_lab.xml EX-101.LAB 287731
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abos-20220331_pre.xml EX-101.PRE 247337
52 EXTRACTED XBRL INSTANCE DOCUMENT d232947d10q_htm.xml XML 719950
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40551 | Film No.: 22929963
SIC: 2836 Biological Products, (No Diagnostic Substances)